Objective To compare the cycle control and tolerability of two oral contraceptives containing
20 μg ethinylestradiol and either 150 μg desogestrel or 75 μg gestodene. Methods A …

The aim of this study was to compare contraceptive reliability, cycle control and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene, with a …

This prospective, double-blind, randomized study was conducted to compare the
contraceptive reliability, cycle control, and tolerability of a 23-day versus a 21-day oral …

In a large and open prospective multicenter trial of 12,250 cycles from 2,378 women,
contraceptive efficacy, clinical tolerance and acceptability of a new monophasic …

This prospective, open, randomized study was conducted to compare the contraceptive
reliability, cycle control, and tolerability of a 23-day regimen with 20 μg ethinyl estradiol (EE) …

An open label, non-comparative study was carried out in 22 women over a total of five
cycles. After an untreated cycle, oral administration of 20 μg ethinyl estradiol (EE) with 50 μg …

This clinical investigation of a low-dose, monophasic gestodene-containing oral
contraceptive (75 μg gestodene/30 μg ethinylestradiol), investigated contraceptive efficacy …

The monophasic low-dose contraceptive containing 30 μg of ethinyl estradiol and 75 μg of
gestodene has been tested in numerous clinical studies to determine contraceptive …

This long-term, open-label, multicenter study investigated the clinical efficacy and tolerability
of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μ ggestodene …

A triphasic oral contraceptive containing ethinyl estradiol and gestodene was used by 1933
women for up to 36 cycles in order to evaluate contraceptive efficacy, general tolerance and …